Dou L, Brunet P, Dignat-George F, Sampol J, Berland Y
Laboratoire d'Hématologie et d'Immunologie, Faculté de Pharmacie, Marseille, France.
Am J Kidney Dis. 1998 Jan;31(1):67-73. doi: 10.1053/ajkd.1998.v31.pm9428454.
Leukocyte Mac-1 (CD11b/CD18) and L-selectin (CD62L) are implicated in leukocyte adhesion to endothelial cells. In this study, L-selectin and CD11b expression on leukocytes and soluble L-selectin (sL-selectin) serum levels were investigated in 17 nondialyzed patients with chronic renal failure (CRF), in 28 chronic hemodialysis patients before hemodialysis (basal state), and in 32 healthy subjects. These parameters were also monitored during hemodialysis with cuprophane and cellulose diacetate membranes in a crossover study in five patients. Granulocytes from CRF patients displayed lower expression of L-selectin and higher expression of CD11b than granulocytes from healthy subjects. On the other hand, baseline expression of L-selectin and CD11b on leukocytes from hemodialysis patients did not differ from that of healthy subjects. In CRF and hemodialysis patients, sL-selectin levels were significantly lower than in healthy subjects. During hemodialysis, cuprophane membrane induced an upregulation of granulocyte CD11b, a decrease in granulocyte L-selectin, and an increase in sL-selectin serum levels. Conversely, cellulose diacetate caused only a transient increase in granulocyte CD11b and did not modify granulocyte L-selectin and sL-selectin serum levels. High CD11b and low L-selectin expression on granulocytes in CRF patients suggests an activation state, which was not found in hemodialysis patients at the basal state. The lack of activation in hemodialysis patients could reflect the elimination of a uremic toxin by dialysis or a loss of granulocyte responsiveness because of the repetitive stimulation by hemodialysis treatment. The low serum levels of sL-selectin in CRF and hemodialysis patients also suggest granulocyte dysfunction.
白细胞Mac-1(CD11b/CD18)和L-选择素(CD62L)与白细胞黏附于内皮细胞有关。在本研究中,对17例未透析的慢性肾衰竭(CRF)患者、28例慢性血液透析患者透析前(基础状态)以及32名健康受试者的白细胞上L-选择素和CD11b的表达以及可溶性L-选择素(sL-选择素)的血清水平进行了研究。在一项交叉研究中,还对5例患者使用铜仿膜和二醋酸纤维素膜进行血液透析期间的这些参数进行了监测。与健康受试者的粒细胞相比,CRF患者的粒细胞显示出较低的L-选择素表达和较高的CD11b表达。另一方面,血液透析患者白细胞上L-选择素和CD11b的基线表达与健康受试者没有差异。在CRF和血液透析患者中,sL-选择素水平显著低于健康受试者。血液透析期间,铜仿膜可诱导粒细胞CD11b上调、粒细胞L-选择素降低以及sL-选择素血清水平升高。相反,二醋酸纤维素仅导致粒细胞CD11b短暂增加,并未改变粒细胞L-选择素和sL-选择素血清水平。CRF患者粒细胞上高CD11b和低L-选择素表达提示一种激活状态,而在血液透析患者的基础状态下未发现这种情况。血液透析患者缺乏激活可能反映了透析对尿毒症毒素的清除或由于血液透析治疗的反复刺激导致粒细胞反应性丧失。CRF和血液透析患者中sL-选择素的低血清水平也提示粒细胞功能障碍。